C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 498/18 (2006.01) A61K 31/529 (2006.01) A61K 31/5386 (2006.01) A61K 31/55 (2006.01) A61P 31/18 (2006.01) C07D 471/08 (2006.01) C07D 471/18 (2006.01) C07D 487/08 (2006.01) C07D 493/18 (2006.01)
Patent
CA 2718950
The disclosure generally relates to the novel compounds of formula I, including their salts, which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV. Formule (I).
L'invention concerne de nouveaux composés de la formule I, y compris leurs sels, qui inhibent l'intégrase du VIH et empêchent une intégration virale dans l'ADN humain. Cette action rend les composés utiles pour traiter une infection du VIH et le SIDA. L'invention englobe également des compositions et procédés pharmaceutiques pour traiter les personnes infectées par le VIH.
Beaulieu Francis
Connolly Timothy P.
Li Chen
Meanwell Nicholas A.
Naidu B. Narasimhulu
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Bridged heterocycles as hiv integrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bridged heterocycles as hiv integrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bridged heterocycles as hiv integrase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1437074